Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma Bằng Jun Wang (15051911)

Những chủ đề:

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with... Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes Bằng Nicola S. Meagher (15048462)

Những chủ đề:

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Can... Bằng Raphaël Leman (17314506)

Những chủ đề:

Figure S2 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề:

Supplementary Tables 1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Canc... Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề:

Figure S4 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề:

Figure S5 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề:

Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề:

Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2⁺ Breast Cancer Bằng Jamunarani Veeraraghavan (16461809)

Những chủ đề: